USPTO trademark

CHAIN DRUG REVIEW

Opposition periodUSPTOWord markClass 9Class 16Class 41

"CHAIN DRUG REVIEW" is a word mark owned by Racher Press, Inc, filed at the USPTO on December 18, 2025. It is in its opposition period and covers classes 9, 16 and 41.

Get this data via the API

Data current as of October 13, 2026Official USPTO record

As filed with the USPTO

Status: Opposition period; Since October 13, 2026
Filed: December 18, 2025
Registered: Not yet
Expires: Not recorded
Application no.: 99554637
Registration no.: Not yet
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 3 classes

Ownership

Who owns CHAIN DRUG REVIEW

The owner and representative on file with the office.

Owner

Racher Press, Inc

New York, United States

Representative

Michael Lazzara

Leech Tishman Fuscaldo & Lampl, LLC

Goods and services

What the mark covers

The products and services CHAIN DRUG REVIEW is filed for, grouped by Nice class.

09Class 9 · Computers and Scientific Devices
Downloadable magazines in the field of retail trade
16Class 16 · Paper Goods and Printed Matter
Printed magazines in the field of retail trade
41Class 41 · Education and Entertainment
Providing on-line non-downloadable magazines in the field of retail trade

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 13, 2026Official gazette publication confirmation e-mailed
October 13, 2026Published for opposition
October 7, 2026Notification of notice of publication e-mailed
September 14, 2026Approved for pub - principal register
August 17, 2026Teas/email correspondence entered
August 17, 2026Correspondence received in law office
August 17, 2026Teas response to office action received
May 20, 2026Notification of non-final action e-mailed
May 20, 2026Non-final action e-mailed
May 20, 2026Non-final action written

7 earlier steps on the official record.

FAQ

About CHAIN DRUG REVIEW

Who owns the trademark "CHAIN DRUG REVIEW"?

The USPTO trademark "CHAIN DRUG REVIEW" (application 99554637) is owned by Racher Press, Inc.

What is the status of "CHAIN DRUG REVIEW"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CHAIN DRUG REVIEW and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2b78-2945-759c-a86c-4a5650e5ecb7
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2b78-2945-759c-a86c-4a5650e5ecb7",
  "object": "trademark",
  "mark_text": "CHAIN DRUG REVIEW",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99554637",
  "filing_date": "2025-12-18",
  "nice_classes": [
    9,
    16,
    41
  ],
  "owners": [
    {
      "name": "Racher Press, Inc",
      "entity_id": null
    }
  ]
}